NVCR

Novocure

• Simply Wall St·5d ago

  NovoCure (NVCR) Jumps After Strong PANOVA-4 Data Validates TTFields Combo Potential In Pancreatic Cancer

• Reuters·04/01 11:00

  Novocure to report first-quarter results, host conference call and webcast

• TipRanks·04/01 10:06

  Zymeworks appoints Kristin Stafford as CFO

• Reuters·04/01 10:00

  Zymeworks appoints Kristin Stafford as CFO effective April 1, 2026

• TipRanks·03/30 16:30

  NovoCure’s EF-32 Optune® Trial Reaches Completion, Setting Up a Key Catalyst for NVCR Investors

• Simply Wall St·03/29 08:05

  A Look At NovoCure (NVCR) Valuation After Extended Share Price Weakness

• NASDAQ·03/27 12:10

  Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates

• TipRanks·03/27 10:20

  Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Mirum Pharmaceuticals (MIRM) and NovoCure (NVCR)

• Benzinga·03/26 15:19

  NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer

• Simply Wall St·03/26 14:07

  Does Positive PANOVA-4 Data Alter the Bull Case For NovoCure’s TTFields Platform (NVCR)?

• Seeking Alpha·03/26 12:53

  4 stocks to watch on Thursday: MSFT, LITE, MARA, NVCR

• Seeking Alpha·03/26 11:43

  Novocure mid-stage trial for electric fields device succeeds in pancreatic cancer

• TipRanks·03/26 11:32

  NovoCure Announces Positive Phase 2 PANOVA-4 Pancreatic Cancer Data

• NASDAQ·03/26 11:28

  Novocure Reports Positive Topline Results From Phase 2 PANOVA-4 Trial Of TTFields Therapy

• TipRanks·03/26 11:11

  Novocure announces results from Phase 2 PANOVA-4 trial met primary endpoint